Lam CSP, Ramasundarahettige C, Branch KRH, et al
The clinical success has made GLP-1 receptors meteorically popular, but the drugs are costly, sparking widespread debate about their affordability and accessibility
Retatrutide is being developed for both obesity and type 2 diabetes but is not yet licensed for either indication in the UK
Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan
In cystic fibrosis, NAC provides anti-inflammatory, antioxidant, and antibiofilm effects, with emerging evidence supporting its role in non-CF bronchiectasis
Eight weeks is a community research timeline, not a clinically proven protocol